$0.27
▲ +1.1% Today
as of Jul 22, 09:05 ET
Last 30 days
Recent Press Releases & News
IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow
Overview
52-week range
$0.24
$0.50
12% of range
Avg surprise (last 3)
+27.8%
Avg reaction (last 2)
-1.7%
0% positive
Latest IV / EM
957%
EM ±222.6% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.02 | $-0.02 | 0.0% | — | -3.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.02 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.02 | $-0.03 | +33.3% | — | — | earnings |
| Fri Jun 27, 2025 | Mar/2025 | $-0.01 | $-0.02 | +50.0% | — | 0.0% | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-0.02 | — | — | — | — | financials |
| Tue Dec 31, 2024 | Dec 2024 | $-0.02 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.02 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.03 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.09 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.05 | — | — | — | — | financials |
| Fri Jul 7, 2023 | Mar/2023 | $-0.08 | — | — | — | — | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.02 | -$0.02 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $317,000 | — | $191,000 | $328,000 | $330,000 | $257,000 | $412,000 | $272,000 |
| Cost of revenue | $262,000 | — | $92,000 | $174,000 | $176,000 | $153,000 | $214,000 | $109,000 |
| Gross profit | $55,000 | — | $99,000 | $154,000 | $154,000 | $104,000 | $198,000 | $163,000 |
| Operating income | $-2M | — | $-3M | $-2M | $-1M | $-2M | $-2M | $-2M |
| Net income | $-2M | — | $-2M | $-2M | $-1M | $-2M | $-2M | $-2M |
| EPS (diluted) | $-0.02 | — | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $207,000 | $900,000 | $1M | $454,000 | $405,000 | $470,000 | $2M | $2M |
| Inventory | $638,000 | $640,000 | $658,000 | $1M | $1M | $1M | $2M | $2M |
| Total current assets | $1M | $2M | $2M | $2M | $3M | $3M | $4M | $4M |
| Total assets | $9M | $10M | $10M | $8M | $9M | $9M | $10M | $11M |
| Long-term debt | — | — | $132,000 | $133,000 | $134,000 | $134,000 | $135,000 | $136,000 |
| Total liabilities | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M |
| Total equity | $6M | $7M | $8M | $6M | $6M | $6M | $7M | $8M |